Accendra Health, Inc.
ACH
$1.13
$0.032.27%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.65B | 2.72B | 2.76B | 2.75B | 2.74B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.65B | 2.72B | 2.76B | 2.75B | 2.74B |
| Cost of Revenue | 1.46B | 1.47B | 1.47B | 1.45B | 1.43B |
| Gross Profit | 1.19B | 1.25B | 1.29B | 1.30B | 1.31B |
| SG&A Expenses | 1.04B | 1.06B | 1.07B | 1.07B | 1.07B |
| Depreciation & Amortization | 87.69M | 65.98M | 44.20M | 21.92M | 30.27M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.59B | 2.60B | 2.59B | 2.54B | 2.53B |
| Operating Income | 61.38M | 120.00M | 175.84M | 209.44M | 204.18M |
| Income Before Tax | -115.48M | -112.80M | -101.95M | -396.02M | -391.43M |
| Income Tax Expenses | -4.89M | -7.46M | 729.00K | 29.08M | 26.81M |
| Earnings from Continuing Operations | -110.59 | -105.34 | -102.68 | -425.10 | -418.23 |
| Earnings from Discontinued Operations | -191.55M | -976.79M | -997.96M | -915.33M | -784.70M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -302.14M | -1.08B | -1.10B | -1.34B | -1.20B |
| EBIT | 61.38M | 120.00M | 175.84M | 209.44M | 204.18M |
| EBITDA | 282.80M | 318.70M | 355.70M | 341.12M | 333.37M |
| EPS Basic | -3.92 | -14.06 | -14.30 | -17.42 | -15.64 |
| Normalized Basic EPS | -0.53 | -0.13 | 0.39 | 0.67 | 0.63 |
| EPS Diluted | -3.93 | -14.06 | -14.30 | -17.42 | -15.64 |
| Normalized Diluted EPS | -0.53 | -0.13 | 0.39 | 0.67 | 0.62 |
| Average Basic Shares Outstanding | 307.11M | 307.35M | 308.19M | 308.24M | 308.04M |
| Average Diluted Shares Outstanding | 307.11M | 307.35M | 308.19M | 308.24M | 309.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |